For the first time, Accenture hosted its HealthTech Innovation Challenge finals at the Texas Medical Center's Innovation Institute. Photo courtesy of Accenture

Two health tech companies walked away from Accenture's HealthTech Innovation Challenge with awards. Regionals took place in Boston and San Francisco, and Houston was selected to host the finals last week.

New York-based Capital Rx was selected as the 2020 Innovation Champion of the Accenture HealthTech Innovation Challenge, and Minneapolis-based Carrot Health was given the second-place award for Top Innovator. The program, which was first launched in 2016, aims to pair startups with health organizations to drive innovative solutions to real challenges in health care.

"The submissions we received this year demonstrate the momentum of discovery and digital innovation in healthcare," says Brian Kalis, managing director of digital health and innovation at Accenture, in a news release. "Healthcare organizations continue to advance their digital transformation agendas — enhancing access, affordability, quality and experience to drive innovation that improves the lives of consumers and clinicians. We look forward to working with these companies and others to continue to help advance solutions that address the industry's toughest challenges."

Capital Rx, a pharmacy benefit manager, won for its product, the Clearinghouse ModelSM, which connects pharmacies and employers for a more efficient and transparent way to coordinate prescriptions.

"Receiving the designation as Innovation Champion is a validation of our mission to change the way drugs are priced and administered, and it represents the broad support across the country to transform the antiquated and opaque pricing model for prescription drugs," says AJ Loiacono, CEO of Capital Rx, in the release.

Carrot Health, which took second place, has created algorithms to use consumer data analytics to predict and determine health issues. Its MarketView platform weighs in factors including social, economic, behavior, and environmental information.

"It's been a great opportunity to be with Accenture and a broad spectrum of health care players," says Kurt Waltenbaugh, CEO and founder of Carrot Health, in the release. "Being recognized as the Top Innovator will help us expand our footprint toward our goal to change health and serve every person in the U.S."

A total of 11 finalists pitched in Houston at TMCx on Feb, 6. The other finalists included: San Francisco-based Cleo, Boston-based DynamiCare Health, San Francisco-based InsightRX, United Kingdom-based Lantum, Washington, D.C.-based Mira, Denver-based Orderly Health, New York City-based Paloma Health, St. Louis-based TCARE, and Seattle-based Xealth.

It was the first time the challenge was hosted at the Texas Medical Center, and William F. McKeon, TMC president and CEO, took the stage at the event to share the medical city's vision for the future.

"The opportunity to host the HealthTech Innovation Challenge in Houston for the first time re-enforces our city's prominent and ever-expanding designation as a major hub for healthcare innovation nationwide," McKeon says in the release. "As Texas Medical Center heads into a new era of collaborative healthcare research on our forthcoming TMC3 campus, we look forward to maintaining a fruitful long-term partnership with Accenture."

Spaces plans to open a new location in Houston this month, Chevron Technology Ventures invests in autonomous vehicle tech, and more Houston innovation news. Courtesy of Spaces

New coworking space to open, Houston to host Accenture's health tech awards, and more innovation news

Short stories

A lot is happening in the Houston innovation ecosystem — so much that you may have missed a few key news items. Let's hit the highlights, shall we?

Applications are open for major health tech awards program that is coming to town, a Houston corporate venture fund doles out cash to self-driving cars, new coworking space to deliver, a diversity-focused partnership launches, and more Houston innovation news.

Chevron Technology Ventures invests in self-driving cars

Voyage is growing its fleet of self-driving vehicles with the help of a Houston corporate VC fund. Photo via voyage.auto

Silicon Valley's Voyage, a self-driving car technology company, closed its series B round at $31 million. Houston-based Chevron Technology Ventures contributed to the round.

The round's funds will go toward expanding the company's fleet of G2 autonomous vehicles in California and Florida, as well as introduce Voyage's G3 self-driving car, Oliver Cameron, co-founder and CEO at Voyage, writes in a release.

"Chevron has been supporting the public's transportation needs for over 100 years. As our customers' mobility needs and preferences change, we want to continue to be part of their journeys. Our investment in Voyage affirms this commitment," says Barbara Burger, CTV president, in a release. "We established the Future Energy Fund in 2018 with an initial commitment of $100 million to invest in breakthrough technologies that enable the ongoing energy transition. The fund looks for technologies that lower emissions and support low carbon value chains. Our investment in Voyage fits well within the objectives of the Future Energy Fund while also informing our perspective on the changing energy landscape."

Accenture to close out health tech challenge in Houston

accenture

The national challenge will conclude in Houston. Courtesy of Accenture

Applications are open for the fourth annual Accenture HealthTech Innovation Challenge and close on September 22. Finalists will present to judges from global health companies at one of two regional events — in Boston on Nov. 7 or in San Francisco on Dec. 5. The final judging event will take place in Houston on February 6, 2020.

"We look forward to this year's submissions as we continue to identify bold ideas from startups that deliver new solutions for health organizations to improve the lives of consumers, clinicians and employees," says Brian Kalis, managing director of digital health and innovation at Accenture, in a release. "Since its inception, the Accenture HealthTech Innovation Challenge has brought healthcare organizations and startups together to tackle the world's biggest health issues where we have received more than 2,200 applications, invited more than 90 startups to compete and who have benefitted from the guidance of nearly 1,000 executive judges from the healthcare industry."

The submission form, including additional details about the challenge's criteria, eligibility, and requirements, is available at: Accenture HealthTech Innovation Challenge-Health.

GotSpot wins pitch competition

Reda Hicks claimed the win at a military spouse pitch event. Trish Alegre-Smith/Military.com

Reda Hicks, who founded Houston-based GotSpot Inc., won a $15,000 check from the StreetShares Foundation and Samuel Adams' Brewing the American Dream at the Great American Military Entrepreneur at the Military Influencer Conference in Washington, D.C.

GotSpot is a website that allows for people with commercial space — a commercial kitchen, conference room, spare desks, etc. — to list it. Then, space seekers — entrepreneurs, nonprofits, freelancers, etc. — can rent it.

"This award is a game-changer for me," Hicks says to Military.com. "This will allow me to hire more incredible military spouses and help GotSpot on its path to go global."

Rice University launches new sports business course

Rice University

Rice University has a new sports business program. Photo courtesy of Rice University

Rice University, along with the Houston Texans, is introducing a new program for the university's sport management students. Pro Sports: Management is a course designed to teach the business side of the sports world.

"We are thrilled to partner with Rice University on a curriculum that will provide their best and brightest students with insight into the real-world opportunities and challenges facing today's sports teams," says Houston Texans President Jamey Rootes in a release from Rice. "This program is rather unique because our leading executives will work alongside Rice professors to teach current best practices in franchise management across every discipline. We believe that this type of practical industry exposure is the best way to prepare the next generation of leaders in the field of sports management and a valuable contribution to the level of professionalism within our industry."

The classes will be held weekly in the executive offices of the Texans. The course will cover ticketing, public relations, event management, human resources and more.

Spaces plans to open second coworking location in Houston

Spaces, an Amsterdam-based coworking space company that entered the Houston market with a lease in Kirby Grove announced in 2017, plans to open its newest location this month. Courtesy of Spaces

The new Spaces CityCentre One location is planned to open on Monday, September 30. It's the Amsterdam-based company's second coworking space in Houston, with a third already in the works. The first location was in Kirby Grove in 2017, and Spaces Galleria at Post Oak will be opening in the second quarter of 2020.

The CityCentre One location will have over 60,000 square-feet of workspace with perks, including a business club, dedicated desk space, private offices, and seven fully-equipped meeting rooms. Plus, the building is just steps away from CityCentre, a mixed-use development with restaurants, entertainment, housing, and more. Membership pricing starts at $111 a month at the new location.

Cemvita Factory receives more backing from oil and gas industry

Cemvita FactoryCemvita Factory

Houston-based Cemvita Factory, a biotech company that can mimick photosynthesis and convert CO2 into glucose and other substances, has received equity investment from BHP. The amount of the investment was not disclosed.

The investment will help Cemvita Factory continue to develop its biomimicry technology for oil and gas applications to reduce the volume of greenhouse gas emissions.

"This strategic investment fits well with BHP's vision of the future: reducing operational greenhouse gas emissions, reducing environmental impact and the development of low-emissions technology, including increased application of carbon capture, utilization and storage technology," says BHP's chief geoscientist, Laura Tyler, in a release.

Last month, Occidental Petroleum's low carbon subsidiary, Oxy Low Carbon Ventures LLC, announced it invested an undisclosed amount of funds into Cemvita Factory.

Two organizations join forces to promote diversity in the Houston Startup Scene

Impact Hub Houston and The Cannon have teamed up to grow programming and events surrounding diversity. Photo courtesy of The Cannon

In an effort to promote diversity and inclusion within the Houston innovation ecosystem, The Cannon and Impact Hub Houston have teamed up. The collaboration will drive programming and events geared at growing the conversation and resources for startups and entrepreneurs.

"One of Houston's best differentiating qualities is that we are truly a melting pot," says Lawson Gow, founder and CEO of The Cannon, in a news release. "We want our community to reflect the amazing diversity across our city, so we have to move beyond simply discussing diversity and work to create an environment where innovation can thrive and real change can happen. We are confident Impact Hub will be the perfect partner to bring those aspects to our community."

Gow, who is the son of InnovationMap's parent company's CEO, opened the doors to its new 120,000-square-foot facility in July. Impact Hub Houston will have a presence in the space.

"Over the past few years, Lawson and I have brainstormed how we could work together to connect and grow our region's innovation ecosystem and demonstrate how organizations can evolve from competition to true collaboration," says Grace Rodriguez, CEO and Executive Director of Impact Hub Houston, in the release. "I'm so excited that those talks have developed into this partnership: Through The Cannon and Impact Hub Houston, we'll be able to effectively 'meet people where they are' geographically, socially, and culturally, helping diverse entrepreneurs and startups at the myriad intersections of place, purpose, demographics, psychographics, and business growth stages."

Houston innovator nominated for prestigious Silicon Valley award

Alley Lyles is up for an award for her work in digital transformation.

Alley Lyles, digital transformation manager at Direct Energy and Houston startup mentor, was nominated for a Women in IT - Silicon Valley award as Transformation Leader of the Year. The awards event is on October 9.

She is up against Emily Dunn at Anaplan, Windy Garrett at Atos, Manju Abraham at Delphix, Aashima Gupta at Google, Patricia Grant at ServiceNow, and Nataliya Anon at Svitla Systems.

"I am proud to represent Houston in Silicon Valley. The Houston hustle is real. I see it amongst my colleagues who got me here. The hustle isn't always glamorous, so I appreciate the moment when a kid from the East End can shine."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

3 Houston startups named most innovative in Texas by LexisNexis

report card

Three Houston companies claimed spots on LexisNexis's 10 Most Innovative Startups in Texas report, with two working in the geothermal energy space.

Sage Geosystems claimed the No. 3 spot on the list, and Fervo Energy followed closely behind at No. 5. Fintech unicorn HighRadius rounded out the list of Houston companies at No. 8.

LexisNexis Intellectual Property Solutions compiled the report. It was based on each company's Patent Asset Index, a proprietary metric from LexisNexis that identifies the strength and value of each company’s patent assets based on factors such as patent quality, geographic scope and size of the portfolio.

Houston tied with Austin, each with three companies represented on the list. Caris Life Sciences, a biotechnology company based in Dallas, claimed the top spot with a Patent Asset Index more than 5 times that of its next competitor, Apptronik, an Austin-based AI-powered humanoid robotics company.

“Texas has always been fertile ground for bold entrepreneurs, and these innovative startups carry that tradition forward with strong businesses based on outstanding patent assets,” Marco Richter, senior director of IP analytics and strategy for LexisNexis Intellectual Property Solutions, said in a release. “These companies have proven their innovation by creating the most valuable patent portfolios in a state that’s known for game-changing inventions and cutting-edge technologies.We are pleased to recognize Texas’ most innovative startups for turning their ideas into patented innovations and look forward to watching them scale, disrupt, and thrive on the foundation they’ve laid today.”

This year's list reflects a range in location and industry. Here's the full list of LexisNexis' 10 Most Innovative Startups in Texas, ranked by patent portfolios.

  1. Caris (Dallas)
  2. Apptronik (Austin)
  3. Sage Geosystems (Houston)
  4. HiddenLayer (Austin)
  5. Fervo Energy (Houston)
  6. Plus One Robotics (San Antonio)
  7. Diligent Robotics (Austin)
  8. HighRadius (Houston)
  9. LTK (Dallas)
  10. Eagle Eye Networks (Austin)

Sage Geosystems has partnered on major geothermal projects with the United States Department of Defense's Defense Innovation Unit, the U.S. Air Force and Meta Platforms. Sage's 3-megawatt commercial EarthStore geothermal energy storage facility in Christine, Texas, was expected to be completed by the end of last year.

Fervo Energy fully contracted its flagship 500 MW geothermal development, Cape Station, this spring. Cape Station is currently one of the world’s largest enhanced geothermal systems (EGS) developments, and the station will begin to deliver electricity to the grid in 2026. The company was recently named North American Company of the Year by research and consulting firm Cleantech Group and came in at No. 6 on Time magazine and Statista’s list of America’s Top GreenTech Companies of 2025. It's now considered a unicorn, meaning its valuation as a private company has surpassed $1 billion.

Meanwhile, HighRadius announced earlier this year that it plans to release a fully autonomous finance platform for the "office of the CFO" by 2027. The company reached unicorn status in 2020.

---

This article originally appeared on Energy Capital HTX.

UH student earns prestigious award for cancer vaccine research

up-and-comer

Cole Woody, a biology major in the College of Natural Sciences and Mathematics at the University of Houston, has been awarded a Barry Goldwater Scholarship, becoming the first sophomore in UH history to earn the prestigious prize for research in natural sciences, mathematics and engineering.

Woody was recognized for his research on developing potential cancer vaccines through chimeric RNAs. The work specifically investigates how a vaccine can more aggressively target cancers.

Woody developed the MHCole Pipeline, a bioinformatic tool that predicts peptide-HLA binding affinities with nearly 100 percent improvement in data processing efficiency. The MHCole Pipeline aims to find cancer-specific targets and develop personalized vaccines. Woody is also a junior research associate at the UH Sequencing Core and works in Dr. Steven Hsesheng Lin’s lab at MD Anderson Cancer Center.

“Cole’s work ethic and dedication are unmatched,” Preethi Gunaratne, director of the UH Sequencing Core and professor of Biology & Biochemistry at NSM, said in a news release. “He consistently worked 60 to 70 hours a week, committing himself to learning new techniques and coding the MHCole pipeline.”

Woody plans to earn his MD-PhD and has been accepted into the Harvard/MIT MD-PhD Early Access to Research Training (HEART) program. According to UH, recipients of the Goldwater Scholarship often go on to win various nationally prestigious awards.

"Cole’s ability to independently design and implement such a transformative tool at such an early stage in his career demonstrates his exceptional technical acumen and creative problem-solving skills, which should go a long way towards a promising career in immuno-oncology,” Gunaratne added in the release.

Houston founder on shaping the future of medicine through biotechnology and resilience

Guest Column

Living with chronic disease has shaped my life in profound ways. My journey began in 5th grade when I was diagnosed with Scheuermann’s disease, a degenerative disc condition that kept me sidelined for an entire year. Later, I was diagnosed with hereditary neuropathy with liability to pressure palsies (HNPP), a condition that significantly impacts nerve recovery. These experiences didn’t just challenge me physically, they reshaped my perspective on healthcare — and ultimately set me on my path to entrepreneurship. What started as personal health struggles evolved into a mission to transform patient care through innovative biotechnology.

A defining part of living with these conditions was the diagnostic process. I underwent nerve tests that involved electrical shocks to my hands and arms — without anesthesia — to measure nerve activity. The pain was intense, and each test left me thinking: There has to be a better way. Even in those difficult moments, I found myself thinking about how to improve the tools and processes used in healthcare.

HNPP, in particular, has been a frustrating condition. For most people, sleeping on an arm might cause temporary numbness that disappears in an hour. For me, that same numbness can last six months. Even more debilitating is the loss of strength and fine motor skills. Living with this reality forced me to take an active role in understanding my health and seeking solutions, a mindset that would later shape my approach to leadership.

Growing up in Houston, I was surrounded by innovation. My grandfather, a pioneering urologist, was among the first to introduce kidney dialysis in the city in the 1950s. His dedication to advancing patient care initially inspired me to pursue medicine. Though my path eventually led me to healthcare administration and eventually biotech, his influence instilled in me a lifelong commitment to medicine and making a difference.

Houston’s thriving medical and entrepreneurial ecosystems played a critical role in my journey. The city’s culture of innovation and collaboration provided opportunities to explore solutions to unmet medical needs. When I transitioned from healthcare administration to founding biotech companies, I drew on the same resilience I had developed while managing my own health challenges.

My experience with chronic disease also shaped my leadership philosophy. Rather than accepting diagnoses passively, I took a proactive approach questioning assumptions, collaborating with experts, and seeking new solutions. These same principles now guide decision-making at FibroBiologics, where we are committed to developing groundbreaking therapies that go beyond symptom management to address the root causes of disease.

The resilience I built through my health struggles has been invaluable in navigating business challenges. While my early career in healthcare administration provided industry insights, launching and leading companies required the same determination I had relied on in my personal health journey.

I believe the future of healthcare lies in curative treatments, not just symptom management. Fibroblast cells hold the promise of engaging the body’s own healing processes — the most powerful cure for chronic diseases. Cell therapy represents both a scientific breakthrough and a significant business opportunity, one that has the potential to improve patient outcomes while reducing long-term healthcare costs.

Innovation in medicine isn’t just about technology; it’s about reimagining what’s possible. The future of healthcare is being written today. At FibroBiologics, our mission is driven by more than just financial success. We are focused on making a meaningful impact on patients’ lives, and this purpose-driven approach helps attract talent, engage stakeholders, and differentiate in the marketplace. Aligning business goals with patient needs isn’t just the right thing to do, it’s a powerful model for sustainable growth and lasting innovation in biotech.

---

Pete O’Heeron is the CEO and founder of FibroBiologics, a Houston-based regenerative medicine company.